Bharat Biotech Covid 19 Vaccine
Bharat Biotech Covid 19 Vaccine News
Bharat Biotech terminates MoU with Brazilian partners for COVID vaccine following graft allegations
Bharat Biotech signed an MoU with Precisa Medicamentos and Envixia Pharmaceuticals in November last year for the purpose of introducing Covaxin in Brazil
Myths around COVID-19 vaccination: COVID-19 vaccine will be mandatory for everyone
Both vaccines currently in use to vaccinate healthcare workers are simultaneously in late-stage human trials to determine their effectiveness.
Bharat Biotech, ICMR publish Covaxin Phase 1 data showing safe, enhanced immunity to Covid-19 disease
Covaxin produced neutralising antibodies against the novel coronavirus – a crucial requirement for protection from Covid-19 disease.
Coronavirus vaccine may hit Indian market by first quarter of 2021, says health minister Harsh Vardhan
Two homegrown vaccine candidates — Covaxin by Bharat Biotech and ZyCOV-D by Zydus Cadila — have almost finished the phase II clinical trials
Emerging landscape of COVID-19 vaccines in India, 14 Aug: Bharat Bio, Zydus move to Phase 2; Biological E, Bayor College tie up for COVID-19 vaccine
Over a dozen Indian companies are in partnership with other firms and institutes to bring a preventive vaccine into global markets by 2021.
Scientists caution govt over plans to fast-track 'Made in India' vaccine, COVAXIN
A virologist said that a vaccine normally takes at least 12-18 months to pass all necessary clinical trial phases while the company developing it has just over a month to wrap up everything
COVID-19 vaccine: ICMR urges institutes chosen for Bharat Biotech's COVAXIN to complete recruitment for human trials by 7 July
The ICMR envisages launching the vaccine for public health use by 15 August after completion of all clinical trials, as per a letter to institutions conducting trials.